The government Tuesday said it has approved 17 FDI (foreign direct investment) proposals amounting to Rs.262.55 crore.
The largest flow of money is related to pharma sector. Sanofi-Synthelabo (India) Limited has got the approval to secure Rs.180 crore FDI. The proposal is for an existing pharma company to acquire another pharma company through internal accruals.
"Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on March 13, 2013, the central government has approved 17 proposals of Foreign Direct Investment amounting to Rs.262.55 crore approximately," the finance ministry said in a statement.
French firm Na Pali Europe SARL has got the approval for induction of foreign contribution in an Indian company to carry out the business of single brand retail trading. It will result in FDI inflow of Rs.7.65 crore.
One proposal has been rejected while the decisions on seven proposals were deferred, the finance ministry said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app